Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 1.736
5-Year Impact Factor – 2.135
Index Copernicus  – 168.52
MEiN – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2016, vol. 25, nr 6, November-December, p. 1173–1177

doi: 10.17219/acem/61612

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Diagnostic and Therapeutic Difficulties in Carotid Body Paragangliomas, Based on Clinical Experience and a Review of the Literature

Karolina Dorobisz1,A,C, Tadeusz Dorobisz2,3,B,D, Hanna Temporale1,A,D, Tomasz Zatoński1,C,E, Marzena Kubacka1,B, Mariusz Chabowski2,4,C,D, Andrzej Dorobisz5,B,E, Tomasz Kręcicki1,D,F, Dariusz Janczak2,4,E,F

1 Department of Otolaryngology, Head and Neck Surgery, Wroclaw Medical University, Poland

2 Department of Surgery, 4th Military Teaching Hospital, Wrocław, Poland

3 Department of Palliative Care and Oncology, Faculty of Health Science, Wroclaw Medical University, Poland

4 Division of Surgical Specialties, Department of Clinical Nursing, Faculty of Health Science, Wroclaw Medical University, Poland

5 Department of Vascular, General and Transplantation Surgery, Wroclaw Medical University, Poland


Background. Paragangliomas are rare neuroendocrine tumors, representing 0.03% of all tumors. Half of them develop in the head and neck, and among these 50% are sporadic cervical tumors.
Objectives. The aim of the study was to carry out an epidemiological and clinical analysis of paraganglioma patients diagnosed and treated at the authors’ clinics between 1985 and 2014.
Material and Methods. The medical data of 47 patients were analyzed. All the patients were qualified for surgery. In 43 cases (88%), simple resection of the tumor was performed, including 11 cases (22%) that additionally required vascular suturing, and 5 (10%) that required reconstruction of the internal carotid artery. Carotid vessel repair was performed by shortening the internal carotid artery in 3 cases (6%), using a saphenous vein graft in 2 cases (4%), and by creating an anastomosis between the external carotid artery and the distal portion of the internal carotid artery in one case (2%).
Results. In 40 cases (82%), the course of treatment was uneventful. Three patients (6%) were reoperated because of symptoms of cerebral stroke. Palsy of the hypoglossal nerve occurred in 3 cases (6%), and facial nerve palsy in 2 patients (4%). Six patients (12%) developed postoperative hematomas in the wound. In all the cases, histopathological examinations confirmed carotid paraganglioma.
Conclusion. Cooperation with an otolaryngologist and vascular surgeon during surgery is recommended due to frequent damage to carotid vessels by carotid paragangliomas. Detection of the tumor in the early stages improves surgical treatment outcomes and reduces the number of complications. Regular postoperative check-ups are necessary due to possible occurrences of multiple tumors.

Key words

diagnosis, surgical treatment, chemodectoma, carotid body paraganglioma, carotid body tumor

References (31)

  1. Nazari I, Aarabi Moghaddam F, Zamani MM, Salimi J: Clinical characteristics and remedies in 45 Iranians with carotid body tumors. Acta Med Iran 2012, 50, 339–343.
  2. Dimakakos PB, Kotsis TE: Carotid body paraganglioma: Review and surgical management. Eur J Plast Surg 2001, 24, 58–65.
  3. Kruger AJ, Walker PJ, Foster WJ, Jenkins JS, Boyne NS, Jenkins J: Important observations made managing carotid body tumors during a 25 year experience. J Vasc Surg 2010, 52, 1518–1524.
  4. Rao AB, Koeller KK, Adair CF: From the archives of the AFIP. Paragangliomas of the head and neck: Radiologicpathologic correlation. Radiographics 1999, 19, 1605–1632.
  5. Von Haller: Cited by Gratiot JH: Carotid tumors: A collective review. Abstr Surg 1943, 7, 117.
  6. Pacheco-Ojeda L: Malignant carotid body tumors: Report of three cases. Ann Otol Rhinol Laryngol 2001, 110, 36–40.
  7. Gilbo P, Morris CG, Amdur RJ, Werning JW, Dziegielewski PT, Kirwan J, Mendenhall WM: Radiotherapy for benign head and neck paragangliomas: A 45-year experience. Cancer 2014, 120, 3738–3743.
  8. Kawai A, Healey JH, Wilson SC, Huvos AG, Yeh SDJ: Carotid body paraganglioma metastatic to bone: Report of two cases. Skeletal Radiol 1998, 27, 103–107.
  9. Westerband A, Hunter GC, Cintora I, Coulthard SW, Hinni ML, Gentile AT, Devine J, Mills JL: Current trends in the detection and management of carotid body tumors. J Vasc Surg 1998, 28, 84–93.
  10. Hensen EF, Bayley JP: Recent advances in the genetics of SDH-related paraganglioma and pheochromocytoma. Fam Cancer 2011, 10, 355–363.
  11. Sanna M, Piazza P, Shin S-H, Flanagan S, Mancini F: Microsurgery of skull base paragangliomas. 1st edition. Thieme. New York 2013.
  12. Neumann HPH, Erlic Z, Boedeker CC, Rybicki LA, Robledo M, Hermsen M, Schiavi S: Clinical predictors for germline mutations in head and neck paraganglioma patients: Cost reduction strategy in genetic diagnostic process as fall-out. Cancer Res 2009, 69, 3650–3656.
  13. Fruhmann J, Geigl JB, Konstantiniuk P, Cohnert TU: Paraganglioma of the carotid body: treatment strategy and SDH-gene mutations. Eur J Vasc Endovasc Surg 2013, 45, 431–436.
  14. Aydogan H, Orhan G, Aykut-Aka S, Albeyoglu S, Yucel O, Sargin M, Goksel O, Filizcan U, Eren EE: Carotid body tumors. Asian Cardiovasc Thor Ann 2002, 10, 173–175.
  15. Flint PW, Haughey BH, Robbins TK, Thomas JR, Niparko JR, Lund VJ, Lesperance MM: Cummings otolaryngology: Head and neck surgery. 5th edition. Mosby Elsevier. Philadelphia 2010.
  16. Rabl H, Friehs I, Gutschi S, Pascher O, Koch G: Diagnosis and treatment of carotid body tumors. Thorac Cardiovasc Surg 1993, 41, 340–343.
  17. Durdik S, Malinovsky P: Chemodectoma – carotid body tumor. Surgical treatment. Bratisl Lek Listy 2002, 103, 422–423.
  18. Gad A, Sayed A, Elwan H, Fouad FMS, Eldin HK, Khairy H, Elhindawy K, Taha A, Hefnawy E: Carotid body tumors: A review of 25 years’ experience in diagnosis and management of 56 tumors. Ann Vasc Dis 2014, 7, 292–299.
  19. Boedeker CC: Paragangliomas and paraganglioma syndromes. Laryngo-Rhino-Otologie 2011, 90, 56–82.
  20. De Toma G, Nicolanti V, Plocco M, Cavallaro G, Letizia C, Piccirillo G, Cavallaro A: Baroreflex failure syndrome after bilateral excision of carotid body tumors: An underestimated problem. J Vasc Surg 2000, 31, 806–810.
  21. Wieneke JA, Smith A: Paraganglioma: Carotid body tumor. Head Neck Pathol 2009, 3, 303–306.
  22. Luna-Ortiz K, Rascon-Ortiz M, Villavicencio-Valencia V, Granados-Garcia M, Herrera-Gomez A: Carotid body tumors: Review of a 20-year experience. Oral Oncol 2005, 41, 56–61.
  23. Sanli A, Oz K, Ayduran E, Aydin S, Altin G, Eken M: Carotid body tumors and our surgical approaches. Indian J Otolaryngol Head Neck Surg 2012, 64, 158–161.
  24. Sajid MS, Hamilton G, Baker DM: A multicenter review of carotid body tumour management. Eur J Vasc Endovasc Surg 2007, 34, 127–130.
  25. Ma D, Liu L, Yao H, Hu Y, Ji T, Liu X, Zhang C, Qiu W: A retrospective study in management of carotid body tumour. Br J Oral Maxillofac Surg 2009, 47, 461–465.
  26. Kotelis D, Rizos T, Geisbüsch P, Attigah N, Ringleb P, Hacke W, Allenberg JR, Bockler D: Late outcome after surgical management of carotid body tumors from a 20-year single-center experience. Langenbecks Arch Surg 2009, 394, 339–344.
  27. Luna-Ortiz K, Rascon-Ortiz M, Villavicencio-Valencia V, Herrera-Gomez A: Does Shamblin’s classification predict postoperative morbidity in carotid body tumors? A proposal to modify Shamblin’s classification. Eur Arch Otorhinolaryngol 2006, 263, 171–175.
  28. Kakkos SK, Reddy DJ, Shepard AD, Lin JC, Nypaver TJ, Weaver MR: Contemporary presentation and evolution of management of neck paragangliomas. J Vasc Surg 2009, 49, 1365–1373.
  29. Qin RF, Shi LF, Liu YP, Lei DL, Hu KJ, Feng XH, Nie X, Mao TQ: Diagnosis and surgical treatment of carotid body tumors: 25 years’ experience in China. Int J Oral Maxillofac Surg 2009, 38, 713–718.
  30. Makeieff M, Raingeard I, Alric P, Bonafe A, Guerrier B, Marty-Ane Ch: Surgical management of carotid body tumors. Ann Surg Oncol 2008, 15, 2180–2186.
  31. Netterville JL, Reilly KM, Robertson D, Reiber ME, Armstrong WB, Childs P: Carotid body tumors: A review of 30 patients with 46 tumors. Laryngoscope 1995, 105, 115–126.